PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30154433-9	2018	In acquired sorafenib-resistant cells, ID1 low expression, p16/IL6 axis up-regulation, and AKT phosphorylation activation were observed.	Sorafenib	12-21	AKT serine/threonine kinase 1	Homo sapiens	91-94	
30154433-10	2018	A reduced cytotoxicity of sorafenib was detected when sorafenib-sensitive cells incubated with conditioned media from the resistant cells, accompanied by the stimulation of AKT phosphorylation.	Sorafenib	26-35	AKT serine/threonine kinase 1	Homo sapiens	173-176	
30154433-11	2018	The reversal of sorafenib resistance could be achieved through ID1 overexpression, IL6 blocking, and AKT pathway inhibition.	Sorafenib	16-25	AKT serine/threonine kinase 1	Homo sapiens	101-104